Hemodynamics in the Cardiac Catheterization Laboratory of the 21st Century

Authors, Journal, Affiliations, Type, DOI

• Rick A. Nishimura, MD (Mayo Clinic College of Medicine, Rochester, MN)
• Blase A. Carabello, MD (Baylor College of Medicine, Houston, TX)
• Circulation 2012;125:2138–2150
• Contemporary review article
• DOI: 10.1161/CIRCULATIONAHA.111.060319

Overview

This contemporary review addresses the evolving role of invasive hemodynamic assessment in the modern cardiac catheterization laboratory. The authors argue that catheterization has shifted from routine pre-surgical evaluation to solving complex diagnostic dilemmas that noninvasive imaging cannot resolve — meaning every case must now yield a definitive answer. Meticulous technique, appropriate catheter selection, and knowledge of provocative maneuvers are emphasized throughout. Specific conditions covered include aortic stenosis, mitral stenosis, valve regurgitation, unexplained dyspnea, pulmonary hypertension, constrictive pericarditis vs restrictive cardiomyopathy, and hypertrophic cardiomyopathy.

Keywords

Catheterization; hemodynamics

Key Takeaways

The New Catheterization Laboratory

• The cath lab has transitioned from a first-line evaluation tool to a diagnostic problem-solver for cases where noninvasive testing is inconclusive or contradictory
• There is "no longer a routine cardiac catheterization" — each study must be goal-directed and individualized
• Operators must be prepared to perform additional provocative interventions (exercise, vasodilators, fluid challenge) if resting data are inconclusive
• Proper equipment: 6F–7F catheters for hemodynamics; side-hole catheters for ventricular pressures; end-hole catheters for wedge pressures; avoid coronary manifold with long extenders
• Constant pressure contour monitoring required to detect artefacts (overdamping, underdamping, catheter entrapment, thrombus)

Valve Stenosis — General Principles

• Valve area is calculated from the same flow equation in both invasive and noninvasive labs: Area = Flow/Velocity
• The Gorlin formula (1951): A = F / (Cc × Cv × √2gh); empirical constant used only for mitral valve; coefficients assumed = 1 for other valves (a theoretical impossibility) — important limitation
• The Hakki equation (simpler ballpark check): valve area = cardiac output / √gradient
• Cardiac output measurement pitfalls: assumed O₂ consumption tables introduce up to 40% error in Fick; thermodilution inaccurate in low-output states, tricuspid regurgitation, intracardiac shunts, and irregular rhythms

Aortic Stenosis

• Doppler echo can underestimate (not overestimate) AS gradient if beam misalignment; continuity equation valve area imprecise due to LVOT diameter squared
• Optimal invasive technique: simultaneous LV and central aortic pressure with side-hole catheters; mean gradient (integrated systolic ejection) preferred over peak-to-peak (non-physiological)
• Femoral artery pressure should NOT be used: peripheral amplification or large-vessel stenosis cause false under/over-estimation of gradient
• Carabello sign: catheter crossing critical AS (≤0.7 cm²) with 7–8F catheter causes further obstruction — recognise before attributing gradient solely to valve
• Pressure contour analysis: fixed obstruction → parvus et tardus; dynamic LVOTO (HCM) → spike-and-dome aortic contour with late-peaking LV pressure
• Braunwald-Brockenborough sign: post-PVC beat shows increased pulse pressure in valvular AS; decreased pulse pressure in HCM — differentiates fixed vs dynamic obstruction
• Low-flow/low-gradient AS (low EF): dobutamine challenge distinguishes true severe AS (gradient increases, valve area remains small ≤0.7 cm²) from pseudo-AS (gradient unchanged, valve area normalises ≥1.2 cm²); inotropic reserve (stroke volume increase ≥20%) stratifies operative risk
• Low-flow/low-gradient AS with preserved EF: high peripheral resistance contributes; nitroprusside challenge can unmask true AS by demonstrating fixed valve area despite lowered afterload

Mitral Stenosis

• Doppler transmitral gradient is highly accurate; echocardiography limitations: half-time method affected by LA/LV compliance and concurrent MR
• Invasive measurement using PAWP vs LV pressure: overestimates true gradient by 30–50% due to phase shift and pressure transmission delay through pulmonary circulation — even after phase-shift correction
• Transseptal approach for direct left atrial pressure mandatory if therapeutic decisions depend on accurate gradient data
• Exercise hemodynamics (supine bicycle) key for symptoms out of proportion to mild/moderate resting stenosis — gradient and PAWP may rise dramatically with exercise

Valve Regurgitation

• Most VR fully evaluated noninvasively; catheterization reserved for discrepancies between clinical examination and echo, or when quantitative measurements are not compatible
• Angiographic grading (Sellar criteria, 1–4 scale) preferred over color-flow for VR: reflects retrograde volume, not velocity artefact
• Technical: large-bore catheters + adequate contrast volume to avoid underestimation; ectopy invalidates ventriculogram — repeat if PVCs occur

Unexplained Dyspnea

• Direct intracardiac/pulmonary pressure measurement required when noninvasive testing is inconclusive in patients with normal LV systolic function without severe VHD
• Afterload reduction (e.g., nitroprusside): high LVEDP that normalises with vasodilators → enhanced ventriculovascular coupling (reversible); failure to normalise → severe irreversible restrictive process → consider endomyocardial biopsy
• High pulmonary pressure: nitric oxide/vasodilator challenge establishes reversibility — caution: NO may worsen filling pressures in patients with elevated baseline LAP
• Exercise hemodynamics (supine bicycle): differentiates pulmonary vs cardiac vs non-cardiac cause; PAWP rise with exercise at low workload indicates non-compliant LA/LV

Pulmonary Hypertension

• Cardiac catheterization mandatory for initial PH evaluation and to distinguish left-sided disease (elevated PAWP) from intrinsic pulmonary vascular disease
• Pulmonary vascular resistance (PVR) = (mPAP − PAWP) / CO; transpulmonary pressure gradient (mPAP − PAWP) is the key numerator
• PAWP confirmation: large-bore end-hole balloon-tipped catheter; saturation ≥95% required to confirm true wedge vs damped PA pressure
• Nitric oxide for vasoreactivity testing only in patients with elevated mPAP and normal PAWP — giving NO when PAWP is elevated risks worsening pulmonary oedema
• Pulmonary artery capacitance has additional prognostic value; should be measured at catheterization

Constrictive Pericarditis vs Restrictive Cardiomyopathy

• Major diagnostic challenge; both may present with right heart failure and elevated equalized diastolic pressures
• Old criteria (absolute PA pressure, RVEDP/RVSP ratio, LVEDP-RVEDP difference) have low specificity — rarely useful individually
• Current criteria: respiratory changes in ventricular interaction
  • Constrictive pericarditis: dissociation of intrathoracic and intracardiac pressures → inspiratory ↓ LV filling → enhanced ventricular interaction through rigid pericardium → discordance of LV and RV pressures during respiration (RV rises as LV falls in inspiration)
  • Restrictive cardiomyopathy: concordance — both LV and RV pressures fall during inspiration
• Volume loading may be required in diuretic-treated patients to bring out classic findings
• Cardiac tamponade: blunted early rapid diastolic filling (vs constrictive); post-pericardiocentesis emergence of constriction = effusive-constrictive pericarditis → pericardiectomy

Hypertrophic Cardiomyopathy

• LVOT gradient ≥50 mmHg (rest or provocation) required for septal reduction therapy; gradient is labile — catheterization needed if noninvasive data inconclusive
• Technical challenges: catheter entrapment in hypertrophied ventricle common — causes erroneous pressures; transseptal approach preferred for LV inflow pressure measurement
• If retrograde catheter: use multipurpose/Rodriquez catheter with distal side holes; avoid pigtail catheters with long side-hole sections
• Provocative maneuvers: Valsalva, PVC induction; if no gradient — isoproterenol infusion (β1+β2 stimulation simulates exercise); useful to unmask labile gradients pre-septal ablation
• Post-ablation: evaluate both resting and provoked gradients

Limitations of the Document

• 2012 publication — predates contemporary TAVI outcomes data, HCM guidelines with mavacamten, and modern low-gradient AS decision algorithms (AHA 2021)
• Many recommendations are expert opinion/practice-based rather than from RCTs
• Equipment and catheter recommendations may not reflect current lab configurations
• Pulmonary hypertension section predates 2022 ESC PH guidelines (new mPAP >20 mmHg threshold)
• No discussion of intravascular ultrasound, FFR, or other modern hemodynamic tools

Key Concepts Mentioned

• concepts/Aortic-Stenosis — Gorlin/Hakki equations; simultaneous LV-Ao gradient; low-flow/low-gradient AS; dobutamine challenge; Carabello sign
• concepts/Mitral-Stenosis — PAWP overestimation of transmitral gradient; direct LA pressure via transseptal
• concepts/Right-Heart-Catheterization — PAWP confirmation technique; wedge vs damped PA pressure; PVR calculation
• concepts/LVOTO — Braunwald-Brockenborough sign; isoproterenol provocation; spike-and-dome aortic pressure pattern
• concepts/Pulmonary-Hypertension — PVR equation; nitric oxide vasoreactivity; capacitance measurement

Key Entities Mentioned

• entities/HCM — hemodynamic assessment; LVOT gradient provocation; septal ablation requirements
• entities/Pulmonary-Hypertension — catheterization technique and vasoreactivity testing
• entities/RCM — constrictive vs restrictive differentiation by respiratory ventricular concordance/discordance

Wiki Pages Updated

• wiki/sources/hemodynamics-circ-2012.md — created
• wiki/sourceindex.md — updated
• wiki/wikiindex.md — updated
• wiki/concepts/Aortic-Stenosis.md — hemodynamic assessment details added
• wiki/concepts/Mitral-Stenosis.md — PAWP overestimation pitfall added
• wiki/concepts/Right-Heart-Catheterization.md — PAWP technique and PVR details added
• wiki/concepts/LVOTO.md — Braunwald-Brockenborough sign, isoproterenol provocation added
• wiki/concepts/Constrictive-vs-Restrictive.md — created (new concept page)
• wiki/entities/HCM.md — hemodynamic catheterization section added